Diabetic Ketoacidosis as an Immune-related Adverse Event from Pembrolizumab in Non-Small Cell Lung Cancer.
journals.lww.com/immunotherapy-journal/Abstra...Posted Jun 3, 2017, 4:59 PM UTC
10
journals.lww.com
Loading comments…
Posted Jun 3, 2017, 4:59 PM UTC